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Spinal Cord Stimulation
for Control of Pain
Stephen Falowski, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

Introduction
Spinal cord stimulation (SCS) is an adjustable, non-destructive procedure which delivers therapeutic
doses of electrical current to the spinal cord for the management of neuropathic pain. The most
common indications include post-laminectomy (“failed back surgery”) syndrome, complex regional
pain syndrome (CRPS), ischemic limb pain, and angina. Other reported applications include
visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic neuralgia, and
neurogenic thoracic outlet syndrome.

History
Advances in technology have driven the popularity of the field. Initially, the contact combinations
could only be hardwired, and could not be reprogrammed after the pulse generator was implanted.
In the beginning, only radio-frequency (RF) driven passive receivers were available. In the midseventies, the first implantable pulse generator powered by a lithium battery was introduced into the
market. In 1980, the first percutaneous electrode was produced, and this could be reprogrammed
non-invasively through an external transmitter.1

Mechanisms of Action
SCS began when Melzack and Wall2 noted that stimulation of large peripheral nerve fibers could
block the sensation of pain. In 1967, Shealy3 inserted the first dorsal column stimulator in a
human suffering from terminal metastatic cancer. Later approaches implanted electrodes via a
laminectomy in the subarachnoid space, between the two layers of the dura, or in the epidural
space.4-6 Subsequently, less invasive percutaneous techniques were introduced.7
The exact mechanisms of action of SCS remain unclear, although computer modeling work has
shed some light on the distribution of complex electrical fields within the spine.8-13 Animal studies
suggest that the SCS triggers the release of serotonin, substance P, and GABA within the dorsal
horn.14, 15 It is not known whether stimulation of different sites—peripheral nerves, dorsal columns,
or supra-lemniscal pathways—will trigger equivalent mechanisms of action.

Indications
SCS has been successfully used for a variety of pain conditions (Table I). Experience suggests that,
in selected patients, SCS can produce at least 50% pain relief in 50-60% of the implanted patients.
Interestingly, with the proper follow-up care, these results can be maintained over several years.
Complex Regional Pain Syndrome (CRPS)
The implementation of SCS in individuals with CRPS type I is more difficult than with any other
patients groups. There is risk of aggravating the original pain or causing a new pain at the implanted
hardware site is greater than with any other diagnostic category mentioned. The CPRS-affected areas
may be too widespread for effective stimulation.

In 1989, Barolat et al. reported reduction of pain in ten out of thirteen patients implanted. No patients

in that series were made pain free but all ten reported a definite difference from stimulation.16 In 1997,
Kumar et al. reported on twelve patients with permanently implanted leads17: eight patients enjoyed
near complete resolution of their symptoms and four also maintained good relief.

Kemler et al. reported 23 additional cases with 78% of the patients reporting improvement.18 A later
study19 compared patients randomized to SCS to those treated with physical therapy. In the SCS
group, 67% of patients experienced significant pain relief which persisted at 6 months. However,
no functional improvement was observed in either group. A 5-year follow-up on the SCS group
indicated that the effects of SCS diminished over time for these patients.20
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Oakley and Weiner reported a prospective
study of 19 patients with CRPS implanted with
spinal cord stimulation systems.21 Of the ten
patients in whom detailed long-term efficacy
data was available, three reported full relief
from their pain and seven, partial beneficial
relief.
Three additional prospective studies without
matched controls have been reported.21-23
Two of the studies reported success rates
with an 84% overall success rate. The third
study by Calvillo et al.22 reported a significant
improvement in pain scores and a >50%
reduction in narcotic use by 44% of subjects. In
eight retrospective studies the overall success
rate was 84% 192 patients.24
Post-laminectomy syndrome aka
Failed back surgery syndrome (FBSS)
Post-laminectomy syndrome is a broad term
which can include pain localized to the lower
lumbar region or the buttocks, persistent
radicular pain, or diffuse lower extremity pain.
Most published series distinguish between
back and leg pain, but seldom define the
details of the pain syndromes. SCS is accepted
in the treatment of leg pain, but its widespread
use for relief of pain in the lower lumbar area
still remains to be defined.
A technical challenge has been to provide
stimulation in the low back, where paresthesia
is often replaced over time by an unpleasant
segmental band of stimulation from the
thoracic roots. Previous pioneering work
by Jay Law25, 26 has shown that stimulation
in the low back can be obtained only if one
uses multiple arrays of closely spaced bipolar
electrodes at T9-T10. North et al. have shown
that one single quadripolar electrode in
midline has the ability to stimulate the axial
low back.27 Flanking the cathode by lateral
anodes also appears to increase the discomfort
threshold theoretically.28
Marchand et al.29 conducted a prospective
randomized controlled study examining patients
with at least one prior surgery for chronic back
pain secondary to trauma. Each patient used
a SCS and acted as his or her own control.
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Although a small trial, with only eight patients,
pain scores were significantly reduced with SCS
compared to placebo stimulation.
The longitudinal studies by North showed
that in patients with post-surgical lumbar
arachnoid or epidural fibrosis without
surgically remediable lesions, SCS provided at
least 50% pain relief in 53% of patients at 2.2
years.30 North et al. also conducted a study
randomizing patients with FBSS to either
repeat back surgery or SCS surgery,33 allowing
crossover after six months. Ten of fifteen
patients crossed over from back surgery
to SCS, while only two of twelve patients
crossed over from SCS to back surgery.
Turner et al.31 systematically reviewed a total
of 41 articles from 1966 to 1994 and noted
that approximately 50-60% of patients with
post-laminectomy greater than 50% pain relief
was attained from the use of SCS. In 1996,
Burchiel et al. conducted a prospective multicenter study with one year follow-up and also
reported 55% successful stimulation.32

Angina
There are well documented reports in the
literature revealing uniformly good results
using SCS to relieve anginal pain.34-38 Further,
the results have been maintained in long term
follow-up and have been substantiated by
a reduction in the intake of nitrates as well.
Interestingly, other findings have supported
the evidence that SCS has effects that go
beyond pain relief. The observations that
there is less ST segment depression and that
the exercise capacity, the time to angina and
the recovery time all improve with stimulation
may suggest that there is a reduction in
ischemia. In a positron emission tomography
study, a redistribution of myocardial flow in
favor of ischemic parts of the myocardium
has been demonstrated as a long term effect of
spinal cord stimulation, both at rest and after
pharmacologic stress induction.39
Vulink et al. conducted a prospective study
on quality of life changes in patients with
refractory angina pectoris implanted with SCS.
They found that both the pain and the health
aspects of quality of life improved significantly
after 3 months of SCS. Further, social, mental
and physical aspects of quality of life were
found improved after one year of SCS.40
Hautvast et al.41 implanted SCS in patients with
stable angina pectoris and randomized them.
One group’s remained inactivated while the
other group was instructed to use the stimulator
three times per day for one hour and with any
angina attack. At 6 weeks, compared with



https://jdc.jefferson.edu/jhnj/vol4/iss1/5
DOI: https://doi.org/10.29046/JHNJ.004.1.002

JHN JOURNAL

controls, the treatment group had increased
exercise duration and time to angina, and
decreased anginal attacks and sublingual nitrate
consumption. Also, observed was a decrease
in ischemic episodes on EKG, as well as a
decrease in observed ST segment depressions
on exercise EKG. There was an increase in
perceived quality of life and decrease in pain.
Mannheimer et al.42 randomized 104 patients
accepted for CABG to receive either CABG
(n=51) or SCS (n=53) in the ESBY study.
This study demonstrated that patients
randomized to SCS showed a greater than
30% improvement in Nottingham Health
Profile (NHP) scores compared with baseline,
which was significant and comparable to the
improvement shown by patients randomized
to CABG.43 These results were consistent on
follow up after four years. It is important to
know that the five-year mortality of 27.9%
in the ESBY study was similar between those
receiving SCS and those who received CABG,
with no difference in the percentage of cardiac
deaths. The ESBY study showed that cardiac
events were similar across the groups, but that
there was significantly more cerebrovascular
events observed in the CABG group.
Both groups experienced a significant
reduction in both the number of angina attacks
and the consumption of nitrates. There was
no significant intergroup difference regarding
these parameters. In another prospective
study of 104 patients who underwent SCS
implantation for refractory angina pectoris
there was a significant decrease in angina
episodes at rest, angina episodes with activity,
and total angina episodes 44
DeJongste et al.36 randomized seventeen
patients with angina to an active treatment
group (i.e. SCS implantation) and a control
group. The control group was followed for
two months followed by SCS implantation.
Both groups were followed for a total of 12
months. This study also revealed a statistically
significant reduction in the incidence of angina
attacks and in the consumption of nitrates.
Five additional studies are reported to be prospective but without matched controls.36, 40, 45-48
Each of these revealed significant benefit from
spinal cord stimulation. The benefit indices
ranged from reduction in angina attacks,
decrease nitrate consumption, decrease in
NYHA grade and improvement in NHP grade.
Andersen et al. reported that out of 45 patients
treated with SCS for anginal pain, there were
three who had also survived a myocardial
infarction49: all three patients noticed the pain

to be different and unrelieved with SCS and
all patients correctly guessed that the pain was
due to a myocardial infarction. The authors
concluded that SCS reduces the severity of
anginal attack, but was unable to suppress the
conduction and perception of cardiac pain
signals which act as alarm signals of cardiac
distress. Similarly, Murray et al. have shown
that SCS for refractory angina is effective
in preventing hospital admissions without
masking the ischemic symptoms or leading to
silent infarction.50
How SCS reduces angina is unclear.
Hautvast et al.41 demonstrated no significant
changes in heart rate variability after 6 wks,
concluding that autonomic modulation of
heart rate may not be the mechanism of
action. There SCS may reduces myocardial
ischemia via homogenization of myocardial
blood perfusion.39,51 SCS can improve lactate
metabolism in the heart muscle, and lactate
metabolism, oxygen demand and blood
flow in the coronary sinus.52 SCS does not
effect variability in heart rates or cardiac
arrhythmias.35, 53, 54
We do not know whether the pain relief is
due to direct depression of the nociceptive
signals in the spinal cord or whether there
is secondary gain from a reduction in the
ischemia.55,56 Foreman has shown that
dorsal column stimulation inhibits the
activity of spinothalamic tracts cells evoked
by activation of the cardiac sympathetic
afferents or by intracardiac bradykinin.14
On the other hand the stimulation might
producing a prolonged inhibition of the
hyperactive sympathetic system, as was shown
experimentally in the rat by Linderoth et al.15
The most appropriate electrode location for
the treatment of angina pectoris is most likely
the lower cervical and upper thoracic region,
although some have reported successful higher
cervical placements.42 Another consideration
is continuous versus cyclical use of SCS. In
practice, patients using SCS for angina pectoris
often use a low intensity stimulation for several
hours per day for prophylactic purposes.57
Recently, a randomized control study
demonstrated improvement in functional
status and symptoms in treatment arms with
conventional or sub threshold stimulation
in comparison to a low output placebo
treatment arm.58

Abdominal/Visceral Pain
Syndromes
Approximately 20% of the population in
United States have abdominal pain. There are
many etiologies for abdominal pain including
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gastrointestinal, genitourinary, musuloskeletal
and nervous systems. Treatment modalities
have included cognitive- behavioral, physical,
and pharmacological therapies. Other more
invasive therapies have extended to include
celiac plexus blocks and celiac ganglia
destruction. Some studies have demonstrated
some localization in the spinal cord for visceral
pain secondary to malignancy. Midline
myelotomy through the dorsal columns at
the level of T10 has shown success in eight
patients with refractory pelvic cancer pain.
This was also demonstrated in animal studies
where dorsal column activity was observed in
pelvic visceral nociception.59
Several studies have demonstrated the benefit
of SCS in abdominal visceral disease. Ceballos
et al.60 demonstrated reduction in pain scores
and decrease in narcotic use in a patient treated
for mesenteric ischemia. Krames et al.61
described a patient treated for irritable bowel
syndrome who was developing escalating pain
and diarrhea. In the first 6 months there was
a subjective decrease in pain on a 10-point
scale from 9/10 to 2/10, with only two diarrhea
episodes and with significant reduction in pain
medications. There was some return of pain
after ten month follow-up, but still a significant
reduction in diarrhea. Khan et al.62 reported
on the largest series with nine patients with
refractory abdominal pain, all of whom had a
significant improvement in pain scores as well
as decreased narcotic use at six to eight month
follow up.
Tiede et al. described treatment of refractory
abdominal pain in two patients. Both patients
had a significant history including multiple
abdominal surgeries and failed conservative
measures. Each patient had an element of
postprandial abdominal pain with associated
nausea and vomiting. In both patients the leads
were placed at the T2 level with significant
improvement in pain, decreased narcotic use
and increase functioning, such as return to
work63. Kapur et al.64 recently described relief
of abdominal pain associated with colchicine
intolerant or resistant patients with familial
Mediterranean fever by placement of the
electrodes at the lower thoracic levels.
More recent studies have looked at the
treatment of visceral pelvic pain with
reference to the dorsal columns and spinal
cord stimulation. Kapural et al.65 reported
on the value of neurostimulation for chronic
visceral pelvic pain in six female patients with
the diagnosis of long-standing pelvic pain.
These patients had a history of endometriosis,
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multiple surgical explorations, and dyspareunia.
At an average follow up of 30 months there was
a significant decrease in the pain score with an
average of more than 50% pain relief, with a
decrease in opiate use.

electrodes, permanent plate electrodes, totally
implantable rechargeable and non-rechargeable pulse generators (IPG) and radiofrequency
(RF) driven pulse generators.

Visceral innervation follows the embryologic origin and location of the viscera and is
arranged in viscerotomes, analogous to cutaneous dermatomes.66 The viscera obtain their
innervation via the sympathetic and parasympathetic pathways. The parasympathetics carry
their afferents to anterior and posterior vagal
trunks and are therefore not as amendable
to spinal cord stimulation. The sympathetics
carry nociceptive information from the viscera
to spinal nerve roots making them a more
viable target. The sympathetic afferents in the
lower six thoracic and the upper three lumbar
spinal segments have been shown to transmit
painful impulses from the viscera 67.

Equipment (Electrodes and
pulse generators)

There are various implantable technologies

existing for SCS. These include trial percutaneous electrodes, permanent percutaneous

Percutaneous electrodes
Percutaneous electrodes can be inserted without
much dissection and can easily be removed
in the implanting physician’s office. During
implantation, these electrodes can be advanced
over several segments in the epidural space,
allowing testing of several spinal cord levels to
assess for optimal electrode position.
Contemporary percutaneous electrodes are
slim electrodes, only a few millimeters in
diameter and containing four or eight contacts
(referred to as either quadripolar or octopolar
electrodes). Choosing the particular electrode
entails deciding how many segments of the spinal cord are to be covered, with larger spacing
allowing broader coverage. Alternatively, closer
spacing allows better steering and electric field
shaping. Additionally, multiple parallel electrodes and different configuration matrices
can be constructed which can create extremely
focused electrical fields.

Figure 2
The above graphic on the left shows a patient who had an L4,5 and L5,S1 anterior posterior
fusion for back and leg pain from lumbar spondylolisthesis. She continued to have
both back and leg pain despite a successful lumbar reconstruction. An ANS (Advanced
Neuromodulation System) tripole electrode was implanted in the thoracic spine. There are
three columns of electrodes. The middle covers the back and the lateral columns provide
stimulation into the legs. The electrode was placed in the operating room with fluoroscopy
and intra-operative EMG monitoring under general anesthesia.
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Plate electrodes
Plate-type electrodes (or ribbon electrodes,
paddle electrodes, or laminotomy electrodes)
require a surgical procedure, laminotomy, and
implantation under direct vision. Implantation
under direct vision may be safer in the upper
thoracic and cervical areas, where there is
a risk of damaging the spinal cord with the
large bore Touhy needle. Most implants can
be done through a skin incision between 2.5
cm and 4 cm long, depending on the size of
the patient and spinal anatomy. The amount
of bony removal is usually minimal.
The main advantage of plate electrodes is
their greater inherent stability, with less to
migrate. Plate electrodes are also more energy
efficient. Multiple arrays or different electrode
configurations can be constructed with plate
electrodes. As with percutaneous leads, there
are varying lengths, and shapes—such as
curved leads and hinged leads, all designed to
help facilitate insertion and tailor the electrode
selection to the patient. They are a preferred
option in the case of previous spine surgery at
the implant levels.
North et al. have published on comparison
between plate and percutaneous electrodes.68
Laminectomy electrode placement, although
more invasive than percutaneous placement,
yielded significantly better clinical results in
patients with failed back surgery syndrome
at up to 3-year follow up. Clinical success was
defined as at least 50% pain relief and patient
satisfaction with treatment. Secondary outcome
measures were ability to perform various
activities of daily living, neurological function,
and analgesic use. There is some theoretical
evidence that shaping of the electrical field is
possible with even more complex electrode
arrays. Holsheimer et al.69 concluded that the
transverse tripolar system enabled finer control
of paresthesia. Electrical field steering could
change the paresthesia area completely. Using
transverse tripolar configurations increases
the threshold for stimulation of dorsal roots.
This results in a wider therapeutic range, wider
paresthesia coverage, and a greater probability
to fully cover the painful area with paresthesia.
Rechargeable and Non-rechargeable
Pulse Generators and RadioFrequency Receivers
Electrical stimulation consists of rectangular
pulses delivered to the epidural space through
implanted electrode via a power source. Two
basic types of systems are currently available:
an Internal Pulse Generator (IPG; also
called the battery) or a radiofrequency (RF)
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coupled pulse generator with an implantable
receiver. The later has largely fallen out of
favor due to the inconveniences of having an
external power source. However, the advent
of the totally implantable, rechargeable
pulse generator has surmounted the power
requirement issues, which were previously the
main RF advantage.
The totally implantable pulse generator
contains a lithium battery. Activation
and control occur through an external
transcutaneous telemetry device. The IPG
can be turned on and off through a small
controller which the patient can carry. The
controller also allows some control over
the stimulation parameters. More extensive
control of the unit can be achieved through a
small portable unit which can be programmed
by the physician. Life span of the battery varies
with usage and with the utilized parameters
(voltage, rate, pulse width, etc.). Most patients
can expect that the battery will last from 2.5
to 4.5 years. Available lithium powered pulse
generators allow stimulation with fine control
of stimulation amplitude, pulse width and
rate. Replacement of the battery requires a
surgical procedure which is usually performed
on an outpatient basis.
Radio frequency (RF) driven systems,
consist of a passive receiver, implanted
subcutaneously, and a transmitter which is
worn externally. An antenna applied to the
skin in correspondence of the receiver is
connected to the transmitter, which sends
the stimulation signals transcutaneously. RF
systems have the inconvenience of having
to wear the antenna and the radio-receiver,
replacing the batteries on a regular basis,
and ensuring proper contact of the antenna
on the skin. These issues may be critical
for individuals with limited upper-limb
motor function. Other patients, particularly
individuals who have reflex sympathetic
dystrophy (RSD), may not tolerate the antenna
taped to the skin. However, what one loses in
convenience, however, is gained in power
and flexibility. Currently only RF systems
can provide a stimulation rate up to 1,400
Hz. This might be beneficial in some patients
with neuropathic chronic pain syndromes70
as well as in patients with extrapyramidal
motor disorders.

inherent in any spine surgery. Infection of
the implanted hardware has occurred with
a 3-5% rate. Persistent pain at the implant
site has been seen in about 5% of patients.
Recalcitrant cerebrospinal fluid leakage has
been encountered in a few patients, requiring
multiple surgical revisions. Breakage or
malfunction of the implanted hardware,
particularly the electrodes and the subcutaneous
extension cables has been encountered in
about 10% of the implanted systems. Painful
stimulation, necessitating either repositioning
or removal of the electrode, has also been
reported in a number of cases.

Conclusions
The treatment of chronic pain remains
challenging. Spinal cord stimulation has been
performed for over 30 years, and slow but
steady progress with this technology has been
made. As the equipment and stimulation
parameters are improved, selection criteria
have been better defined and are slowly being
expanded. More importantly, experience in
the technique and the equipment has made
SCS a much more reliable and safe modality.
Like all the modalities performed for chronic
pain management, its results are favorable.
It is important to remember that the goal of
neurostimulation is to reduce pain, rather than
to eliminate pain. It has been shown to have a
50% improvement in pain relief, and reduce
the use of more medications Very few other
invasive modalities can claim this success rate
with a few years of follow-up.
Careful follow-up of the patients is necessary for
successful long-term satisfaction. Equipment
related problems can arise at any time after
implantation, such as discomfort at the
pulse generator/radio receiver site, electrode
breakage or migration, infection, etc., and an
open dialogue with the patients is vital for the
continuing successful implementation of the
modality. Spinal cord stimulation has earned a
well established and firm role in contemporary
chronic pain management.
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